sPLA2-V inhibits EPCR anticoagulant and antiapoptotic properties by accommodating lysophosphatidylcholine or PAF in the hydrophobic groove

The endothelial cells downregulate the generation of factor VIIa through EPCR binding

(2010) Cristina Puy et al.   BRITISH JOURNAL OF HAEMATOLOGY

Blocking endothelial protein C receptor (EPCR) accelerates thrombus development in vivo

(2010) Miguel Centelles et al.   THROMBOSIS AND HAEMOSTASIS

Role of activated protein C and its receptor in inhibition of tumor metastasis

(2009) M. Bezuhly et al.   BLOOD

The cellular and biochemical rules of lipid antigen presentation

(2009) Gennaro De Libero et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

(2009) A. R. FOLSOM et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Determination of Cellular Lipids Bound to Human CD1d Molecules

(2009) Daryl Cox et al.   PLoS One

Recognition of Lyso-Phospholipids by Human Natural Killer T Lymphocytes

(2009) Lisa M. Fox et al.   PLOS BIOLOGY

Secretory PLA2 inhibitor indoxam suppresses LDL modification and associated inflammatory responses in TNFα-stimulated human endothelial cells

(2008) K Sonoki et al.   BRITISH JOURNAL OF PHARMACOLOGY

Recombinant expression of biologically active murine soluble EPCR

(2008) Jacinto López-Sagaseta et al.   PROTEIN EXPRESSION AND PURIFICATION